Imugene Stock Quote IMU - Stock Price, News, Charts, Message Board, Trades

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Premium

Current Price

0.042

Bid

0.042

Ask

0.043

Volume

40,813,474

0.038 Day's Range 0.0435

0.035 52 Week Range 0.13

Market Cap

307.432M

Previous Close

0.038

Open

0.039

Last Trade

0.042

Last Trade Time

Financial Volume

VWAP

Average Volume (3m)

18,260,880

Shares Outstanding

7,319,810,809

Dividend Yield

PE Ratio

-1.96

Earnings Per Share (EPS)

-0.02

Revenue

4.97M

Net Profit

-149.68M

Sector

Biological Pds,ex Diagnstics

Industry

Biotechnology Animal & Plant

Website

www.imugene.com

Headquarters

Melbourne, Victoria, Aus

Founded

1986

Imugene Limited is listed in the Biological Pds,ex Diagnstics sector of the Australian Stock Exchange with ticker IMU. The last closing price for Imugene was AUD0.04. Over the last year, Imugene shares have traded in a share price range of AUD 0.035 to AUD 0.13.

Imugene currently has 7,319,810,809 shares outstanding. The market capitalization of Imugene is AUD278.15 million. Imugene has a price to earnings ratio (PE ratio) of -1.96.

RenovoRx and Imugene Announce Collaboration to Deliver Oncolytic Virus Therapy Using Proprietary Trans-Arterial Micro-Perfusion (TAMP™) Platform

Collaboration will explore trans-arterial delivery of Imugene’s CF33 oncolytic virus utilizing RenovoRx’s TAMP therapy platform. TAMP is expected to enable localized, targeted delivery of CF33...

Imugene Announces Clinical Trial Supply Agreement with Merck KGaA, Darmstadt, Germany and Pfizer to Evaluate HER-Vaxx in Combination with Avelumab for Treatment of Gastric Cancer

New clinical trial supply agreement with Merck KGaA, Darmstadt, Germany and Pfizer Inc.Avelumab (BAVENCIO®) to be provided to Imugene for Phase 2 clinical study in HER-2 positive gastric or...

Imugene and Eureka Therapeutics Announce Strategic Collaboration to Accelerate Advancement of Oncolytic Virus and T-Cell Therapy in Solid Tumours

The Collaboration will evaluate Eureka’s anti-CD19 ARTEMIS® T-cell therapy in combination with Imugene’s CD19-expressing oncolytic virus onCARlytics in solid tumours Potential to address lack of...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0.004	10.5263157895	0.038	0.0435	0.037	9691203	0.03853203	DE
4	-0.005	-10.6382978723	0.047	0.049	0.035	19198013	0.04114972	DE
12	-0.012	-22.2222222222	0.054	0.055	0.035	18260880	0.04641321	DE
26	-0.025	-37.3134328358	0.067	0.081	0.035	19806414	0.05290212	DE
52	-0.058	-58	0.1	0.13	0.035	19614925	0.07293643	DE
156	-0.478	-91.9230769231	0.52	0.535	0.035	22860383	0.14184714	DE
260	0.003	7.69230769231	0.039	0.625	0.016	21458653	0.16512385	DE

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
PENPeninsula Energy Ltd	AUD 1.19 (2,063.64%)	542.62k
SPASpacetalk Ltd	AUD 0.19 (1,017.65%)	10k
NRZNeuRizer Ltd	AUD 0.003 (100.00%)	13.91M
ADNOCAndromeda Metals Limited	AUD 0.002 (100.00%)	295.92k
VPRVolt Group Ltd	AUD 0.002 (100.00%)	3.65M
AMSOAtomos Limited	AUD 0.001 (-80.00%)	16.5k
TMSOTennant Minerals Ltd	AUD 0.001 (-50.00%)	1M
1TTThrive Tribe Technologies Ltd	AUD 0.001 (-50.00%)	515.72k
CYBAUCyber Ltd	AUD 0.13 (-35.00%)	1.29M
HCDHydrocarbon Dynamics Limited	AUD 0.002 (-33.33%)	12k
MMIMetro Mining Ltd	AUD 0.062 (-1.59%)	175.82M
M4MMacro Metals Ltd	AUD 0.018 (63.64%)	56.98M
IMUImugene Limited	AUD 0.042 (10.53%)	40.81M
ROGRed Sky Energy Limited	AUD 0.009 (-18.18%)	33.58M
DEGDe Grey Mining Limited	AUD 1.905 (-0.26%)	31.99M